Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
02/2000
02/10/2000WO2000006554A1 Lipid-lowering quinazoline derivative
02/10/2000WO2000006534A1 Compounds and compositions for delivering active agents
02/10/2000WO2000006254A2 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
02/10/2000WO2000006200A1 Lowering of serum cholesterol by ingestion of antibodies to cholesterol
02/10/2000WO2000006195A1 Targeting pharmaceutical agents to injured tissues
02/10/2000WO2000006185A2 Methods of using lanreotide, a somatostatin analogue
02/10/2000WO2000006184A1 Pulmonary delivery of active agents
02/10/2000WO2000006147A1 Macrophage scavenger receptor antagonists
02/10/2000WO2000006140A2 Use of moclobemide for treating certain phsychiatric and medical disorders
02/10/2000WO2000006138A2 Use of moclobemide for treating pain and other diseases
02/10/2000WO2000006126A1 Rapidly disintegrable solid preparation
02/10/2000WO1999061600A3 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
02/10/2000CA2581111A1 Rapidly disintegrable solid preparation
02/10/2000CA2525555A1 Rapidly disintegrable solid preparation
02/10/2000CA2339094A1 Macrophage scavenger receptor antagonists
02/10/2000CA2338825A1 Lipid-lowering quinazoline derivative
02/10/2000CA2338694A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them
02/10/2000CA2338643A1 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof
02/10/2000CA2338330A1 Use of moclobemide for treating certain phsychiatric and medical disorders
02/10/2000CA2338327A1 Use of moclobemide for treating pain and other diseases
02/10/2000CA2338019A1 Prostate derived ets factor
02/10/2000CA2336543A1 Isoforms of human calcium sensing receptor
02/10/2000CA2335656A1 Human cytoskeletal proteins
02/10/2000CA2335654A1 Methods of using a somatostatin analogue
02/09/2000EP0978284A1 Endothelin antagonist
02/09/2000EP0978278A1 Diabetes remedies
02/09/2000EP0977879A2 Eukaryotic gene expression cassette and uses thereof
02/09/2000EP0977873A1 Method for cleavage of fusion proteins
02/09/2000EP0977753A1 Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
02/09/2000EP0977751A1 Somatostatin agonists
02/09/2000EP0977741A1 Substituted phenyl derivatives, their preparation and use
02/09/2000EP0977734A2 Arylsecocholadiene derivatives
02/09/2000EP0977586A1 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
02/09/2000EP0977585A1 Methods for diagnosing and treating body weight related disorders in animals
02/09/2000EP0977583A1 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
02/09/2000EP0977573A1 Use of an nk-1 receptor antagonist and an ssri for treating obesity
02/09/2000EP0977564A1 Forskohlin for promoting lean body mass
02/09/2000EP0828434B1 Fat based food products
02/09/2000EP0746332B1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
02/09/2000CN1244193A Novel amide derivatives and medicinal compositions thereof
02/09/2000CN1244128A Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens
02/09/2000CN1244124A Amorphous benzothiophenes, methods of preparation, and methods of use
02/09/2000CN1049222C Propiophenone derivative and processes for preparing the same
02/08/2000US6022978 Benzimidazole derivatives
02/08/2000US6022971 Azetidines
02/08/2000US6022900 Preventing and ameliorating cachexia; treating whole body nitrogen loss associated with catabolic illness by inhibiting synthesis of urea from plasma arginine
02/08/2000US6022899 Effective inhibitors of the cellular sodium proton antiporter
02/08/2000US6022897 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
02/08/2000US6022884 Substituted pyridine compounds and methods of use
02/08/2000US6022697 Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus
02/08/2000CA2150016C Pyrrolopyrimidines as crf antagonists
02/08/2000CA2014467C 3-substituted-2-oxindole derivatives
02/06/2000CA2279747A1 Estrogen agonists/antagonists
02/03/2000WO2000005388A1 Genes of the dead box protein family, their expression products and use
02/03/2000WO2000005270A1 Biocompatible polymers, preparation method and compositions containing same
02/03/2000WO2000005269A1 Polymer complexes of glucuronoglucanes
02/03/2000WO2000005260A1 Peptide analogues of pacap
02/03/2000WO2000005249A2 Synthetic peptides and methods of use for autoimmune disease therapies
02/03/2000WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb
02/03/2000WO2000005224A2 Heterocyclic derivatives and their use as integrin inhibitor
02/03/2000WO2000005223A2 Heterocyclic derivatives and their use as integrin inhibitors
02/03/2000WO2000005207A1 Substituted phenylamidines with antithrombotic action
02/03/2000WO2000005201A1 N-benzocycloalkyl-amide derivatives and their use as medicaments
02/03/2000WO2000004939A1 Dental pin
02/03/2000WO2000004937A1 Flat flexible materials
02/03/2000WO2000004925A1 Slow release formulations comprising anionic polysaccharide
02/03/2000WO2000004907A1 An antilipemic formulation
02/03/2000WO2000004895A2 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers
02/03/2000WO2000004891A2 Anti-ulcer composition
02/03/2000WO2000004890A1 Use of glucose uptake enhancer for reducing apoptosis
02/03/2000WO2000004882A1 Formulations of anionic polysaccharides
02/03/2000WO2000004877A1 Suppository formulations comprising anionic polysaccharide
02/03/2000WO1999034786A3 Lipase inhibiting polymers
02/03/2000WO1998055483A9 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
02/03/2000DE19834714A1 Neue 2,3,3a,4,9,9a-Hexahydro-8-hydroxy-1H-ben[f]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New 2,3,3a, 4,9,9a-hexahydro-8-hydroxy-1H-ben [f] indoles, to processes for their preparation and their use as medicaments
02/03/2000DE19831382A1 Humanes m¶3¶G-cap-spezifisches Kernimportrezeptorprotein mit einer neuen Domänenstruktur, dessen Herstellung und Verwendung Human m¶3¶G-cap-specific nuclear import receptor protein with a new domain tree, its preparation and use
02/03/2000CA2338211A1 Use of glucose uptake enhancer for reducing apoptosis
02/03/2000CA2338198A1 N-benzocycloalkyl-amide derivatives and their use as medicaments
02/03/2000CA2337413A1 Substituted phenylamidines,pharmaceutical compositions containing these compounds and processes for preparing them
02/03/2000CA2336238A1 Synthetic peptides and methods of use for autoimmune disease therapies
02/03/2000CA2335646A1 Genes of the dead box protein family, their expression products and use
02/03/2000CA2335341A1 Peptide analogues of pacap
02/02/2000EP0976406A1 Transdermal composition containing glibenclamide and benzyl alcohol
02/02/2000EP0976398A2 Use of 3,4-diphenyl chroman derivatives in the manufacture of a medicament for lowering serum cholesterol levels and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
02/02/2000EP0975754A1 Osteoprotegerin binding proteins and receptors
02/02/2000EP0975680A1 Interactive system for substance presentation and elimination
02/02/2000EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA
02/02/2000EP0975633A1 5,6,7-trisubstituted-4-aminopyridol 2,3-d]pyrimidine compounds
02/02/2000EP0975624A1 Thermogenic composition and benzazepine thermogenics
02/02/2000EP0975617A1 Inhibitors of cholesterol esterase
02/02/2000EP0975598A1 Process and intermediates for the preparation of 4'-trifluoromethyl-biphenyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide
02/02/2000EP0975589A2 Dialkyl ureas as calcitonin mimetics
02/02/2000EP0975585A1 Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides
02/02/2000EP0975581A1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine choline tartrate
02/02/2000EP0975573A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
02/02/2000EP0975358A2 Method of treating psychological and metabolic disorders using igf or igf/igfbp-3
02/02/2000EP0975357A1 Transdermal delivery system
02/02/2000EP0975356A1 Pulsatile delivery of leptin receptor ligands
02/02/2000EP0975343A1 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
02/02/2000EP0804185B1 Arsenic medicaments for the treatment of chronic fatigue syndrome
1 ... 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 ... 1298